Orthobond Corp.

Orthobond Corporation is an antimicrobial technology company headquartered in Monmouth Junction, NJ, specializing in proprietary nanosurface coatings that kill bacteria, viruses, and fungi through mechanical rupture without antibiotics or eluting chemicals. The company's lead product is Ostaguard™, a proprietary antibacterial surface treatment designed for application to orthopedic implants and devices to prevent device-related infections. Orthobond's core technology involves covalently bonded nanosurfaces on metallic and polymeric substrates that provide durable, non-drug antimicrobial protection. The company is pursuing FDA clearance for its medical device surface treatments and has received venture funding to commercialize its antimicrobial nanosurface platform across orthopedic implants, surgical instruments, and broader medical device categories. Beyond medical devices, Orthobond markets applications for commercial, industrial, textile, and consumer goods sectors. The technology is designed to reduce infection-related complications in orthopedic surgery while maintaining safety for human contact.